Helicobacter heilmannii gastroduodenal disease and clinical aspects in children with dyspeptic symptoms
Language English Country Norway Media print
Document type Journal Article
PubMed
15174799
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- Gastrointestinal Diseases diagnosis drug therapy epidemiology MeSH
- Helicobacter heilmannii drug effects isolation & purification MeSH
- Helicobacter pylori drug effects isolation & purification MeSH
- Helicobacter Infections diagnosis drug therapy epidemiology MeSH
- Cohort Studies MeSH
- Humans MeSH
- Adolescent MeSH
- Prevalence MeSH
- Prospective Studies MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic epidemiology MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
AIM: To evaluate the occurrence and clinical characteristics of Helicobacter heilmannii infection among children presenting with dyspeptic symptoms. METHOD: Prospective cohort study of 580 patients. RESULTS: Of all examined dyspeptic children, 26.4% were infected with spiral-shaped organisms, and 0.9% of patients were found to be infected with spiral H. heilmannii-like organisms. CONCLUSION: In children with dyspeptic symptoms, the possible presence of gastroduodenal disease due to H. heilmannii should be considered. Further studies are needed to clarify H. heilmannii-related gastroduodenal pathology in the paediatric population.
